Empowering Pharma Professionals for Tomorrow’s Challenges
This was the general theme of a meeting that Dr Andreas Keck (Syte Institute, Germany) and I held a few days ago at SINDUSFARMA, in São Paulo, with leaders from the pharmaceutical industry in Brazil.
It was a very productive morning in which my colleague Andreas discussed with the participants the topic Digital Health and AI: Increasing Revenue and Reducing Costs in Pharma, and I the topic Digital Health and AI with Purpose: An Approach for Pharmaceutical Industry Professionals. Here are some of the aspects I addressed on this occasion.
Digital transformation is no longer a technological option, but a strategic necessity for the pharmaceutical industry. The role of leadership is to act as a catalyst for this change, articulating a clear digital vision, promoting integration between areas such as R&D, regulatory affairs, quality and marketing, and fostering a data-driven culture. Digital transformation is organizational change, stakeholder mobilization, and the ability to scale pilots that truly deliver value to the business and the patient.
The purposeful use of Artificial Intelligence connects science and care. AI already accelerates steps such as drug discovery, patient eligibility in clinical trials, pharmacovigilance, and digital solutions focused on the patient journey. But its real value emerges when it unites data, science, clinical validation and decision-making, and concrete impact. Challenges: data, interoperability, ethics, governance, and validation, points that determine whether AI advances safely and relevantly in the sector.
Innovation must have consistency, quality, and safety, indispensable elements in the pharmaceutical environment. Digital solutions and AI models need to follow robust standards of data management, validation, governance, and real-time monitoring. Failures can generate clinical, regulatory, and reputational risks; therefore, sustainable innovation requires process, indicators, a defined lifecycle, integration with corporate IT, and full adherence to requirements (e.g. LGPD, GPDR) and good regulatory practices. Innovation is only viable when it is safe, scalable, and reliable.
Leadership must be purpose-driven, which is fundamental for digital transformation and AI to have a real impact. Leading in the pharmaceutical industry today means anchoring innovation in patient value, fostering internal and external collaboration, developing new digital skills, and establishing clear impact metrics. More than technology, it’s about vision, culture, and responsibility. The future of the sector will depend on leaders capable of uniting purpose, innovation, and rigor, creating solutions that truly improve lives.
